Hydroxyurea-induced nail pigmentation

Journal of the American Academy of Dermatology

Volumn 35, Issue 2 PART I, 1996, Pages 275-276

  Kwong, Y L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BUSULFAN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HYDROXYUREA; MELPHALAN;

AGED; ARTICLE; CASE REPORT; DISEASE SEVERITY; DYSTROPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MYELOPROLIFERATIVE DISORDER; NAIL DISEASE; PRIORITY JOURNAL; SKIN PIGMENTATION; THROMBOCYTE COUNT; THROMBOCYTHEMIA;

AGED; ENZYME INHIBITORS; FEMALE; FINGERS; HUMANS; HYDROXYUREA; HYPERPIGMENTATION; NAIL DISEASES; THROMBOCYTOSIS; TOES;

EID: 0029743897     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(96)90353-9     Document Type: Article

References (6)

1. Baran R, Kechijian P. Longitudinal melanonychia (melanonychia striata): diagnosis and management. J Am Acad Dermatol 1989;21:1165-75.
2. Vomvouras S, Pakula AS, Shaw JM. Multiple pigmented nail bands during hydroxyurea therapy: an uncommon finding. J Am Acad Dermatol 1991;24:1016-7.
3. Kelsey PR. Multiple longitudinal pigmented bands during hydroxyurea therapy. Clin Lab Haematol 1992;14:337-8.
4. Kennedy BJ, Smith LR, Goltz RW. Skin changes secondary to hydroxyurea therapy. Arch Dermatol 1975; 111:183-7.
5. Tosti A, Baran R, Dawber RPR. The nail in systemic diseases and drug-induced changes. In: Baran R, Dawber RPR, editors. Diseases of the nails and their management. Oxford: Blackwell, 1994:135-74.
6. Sulis E, Floris C. Nail pigmentation following cancer chemotherapy: A new genetic entity? Eur J Cancer 1980; 16:1317-9.